布特列罗呼吸法治疗哮喘的系统评价和荟萃分析方案。
Buteyko method for people with asthma: a protocol for a systematic review and meta-analysis.
机构信息
Department of Physical Therapy, Graduate Program in Physical Therapy, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
Department of Physical Therapy, Plymouth State University, Plymouth, New Hampshire, USA.
出版信息
BMJ Open. 2021 Oct 18;11(10):e049213. doi: 10.1136/bmjopen-2021-049213.
INTRODUCTION
Buteyko method is recommended as a non-pharmacological treatment for people with asthma. Although the worldwide interest in the Buteyko method, there is a paucity of studies gathering evidence to support its use. Therefore, we aim to conduct a systematic review and meta-analysis to assess the effects of the Buteyko method in children and adults with asthma.
METHODS AND ANALYSIS
We will search on Cochrane Central Register of Controlled Trials, MEDLINE, Embase, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov and WHO International Clinical Trials Registry Platform for studies focusing on the Buteyko method for children and adults with asthma. The searches will be carried out in September 2021 from database's inception to the present. We will include randomised controlled trials comparing Buteyko method alone with asthma education or inactive control intervention. There will be no restriction on language. Primary outcomes include quality of life, asthma symptoms and adverse events/side effects. Two review authors will independently screen the studies for inclusion and extract data. We will assess the quality of the included studies using the 'Risk of Bias' tool. The certainty of the evidence will be assessed using the GRADE approach. Data synthesis will be conducted using Review Manager software. Reporting of the review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance and the Cochrane Handbook for Systematic Reviews of Interventions.
ETHICS AND DISSEMINATION
This study will assess and provide evidence for the use of the Buteyko method in people with asthma. We will analyse secondary data and this does not require ethics approval. The findings will be published in peer-reviewed journals, at relevant conferences and will be shared in plain language in social media. Moreover, the findings of this review could guide the direction of healthcare practice and research.
PROSPERO REGISTRATION NUMBER
CRD42020193132.
简介
布特科方法被推荐为治疗哮喘患者的非药物治疗方法。尽管全球对布特科方法的兴趣浓厚，但缺乏收集证据支持其使用的研究。因此，我们旨在进行系统评价和荟萃分析，以评估布特科方法对儿童和成人哮喘患者的影响。
方法和分析
我们将在 Cochrane 对照试验中心注册库、MEDLINE、Embase、美国国立卫生研究院正在进行的试验登记处 ClinicalTrials.gov 和世界卫生组织国际临床试验注册平台上搜索针对儿童和成人哮喘的布特科方法的研究。搜索将于 2021 年 9 月进行，从数据库成立到现在。我们将纳入比较布特科方法单独与哮喘教育或非活性对照干预的随机对照试验。语言不受限制。主要结局包括生活质量、哮喘症状和不良事件/副作用。两名综述作者将独立筛选纳入研究并提取数据。我们将使用“偏倚风险”工具评估纳入研究的质量。证据的确定性将使用 GRADE 方法进行评估。使用 Review Manager 软件进行数据分析。报告综述将遵循系统评价和荟萃分析的首选报告项目以及干预措施系统评价 Cochrane 手册的指导。
伦理和传播
本研究将评估并提供布特科方法在哮喘患者中的使用证据。我们将分析二次数据，这不需要伦理批准。研究结果将发表在同行评议的期刊上，在相关会议上，并将在社交媒体上以通俗易懂的语言分享。此外，本综述的结果可能会指导医疗保健实践和研究的方向。
PROSPERO 注册号：CRD42020193132。
Zotero 插件